VOYA Investment Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.77M | Buy |
36,351
+22,481
| +162% | +$1.09M | ﹤0.01% | 1353 |
|
|
2025
Q1 | $472K | Buy |
13,870
+5,210
| +60% | +$177K | ﹤0.01% | 1895 |
|
|
2024
Q4 | $341K | Hold |
8,660
| – | – | ﹤0.01% | 2132 |
|
|
2024
Q3 | $407K | Sell |
8,660
-7,795
| -47% | -$366K | ﹤0.01% | 2114 |
|
|
2024
Q2 | $889K | Sell |
16,455
-9,891
| -38% | -$534K | ﹤0.01% | 1676 |
|
|
2024
Q1 | $1.8M | Hold |
26,346
| – | – | ﹤0.01% | 1383 |
|
|
2023
Q4 | $1.65M | Buy |
26,346
+6,151
| +30% | +$385K | ﹤0.01% | 1453 |
|
|
2023
Q3 | $917K | Buy |
20,195
+7,936
| +65% | +$360K | ﹤0.01% | 1680 |
|
|
2023
Q2 | $688K | Sell |
12,259
-225
| -2% | -$12.6K | ﹤0.01% | 1895 |
|
|
2023
Q1 | $565K | Sell |
12,484
-9,645
| -44% | -$436K | ﹤0.01% | 1982 |
|
|
2022
Q4 | $900K | Sell |
22,129
-55
| -0.2% | -$2.24K | ﹤0.01% | 1693 |
|
|
2022
Q3 | $1.45M | Buy |
+22,184
| New | +$1.45M | ﹤0.01% | 1458 |
|
|
2020
Q1 | – | Sell |
-3,793
| Closed | -$231K | – | 2638 |
|
|
2019
Q4 | $231K | Buy |
+3,793
| New | +$231K | ﹤0.01% | 2308 |
|